Suchergebnisse - "David A. Wohl"

PubPharm (11)

1

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trialResearch in context

in: EClinicalMedicine | 2023

von Prasanna Jagannathan | Kara W. Chew | Mark J. Giganti | +113

2

The prevalence of Post-Ebola Syndrome hearing loss, Sierra Leone

in: BMC Infectious Diseases | 2022

von Samuel C. Ficenec | Donald S. Grant | Ibrahim Sumah | +13

3

Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses

in: JCI Insight | 2022

von Sydney I. Ramirez | Alba Grifoni | Daniela Weiskopf | +17

4

COVID-19 symptoms at time of testing and association with positivity among outpatients tested for SARS-CoV-2

in: PLoS ONE | 2021

von David A. Wohl | Amir H. Barzin | Sonia Napravnik | +8

5

Estimated Impact of Targeted Pre-Exposure Prophylaxis: Strategies for Men Who Have Sex with Men in the United States

in: International Journal of Environmental Research and Public Health | 2019

von Richard A. Elion | Mina Kabiri | Kenneth H. Mayer | +4

6

Patterns of Mood and Personality Factors and Associations With STI/HIV-Related Drug and Sex Risk Among African American Male Inmates

enthalten in: Substance use & misuse | 2017

von Joy D Scheidell | Carl W Lejuez | Carol E Golin | +6

7

Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection : = Non-initiation of hepatitis C virus antiviral therapy in patients with human immunodeficiency virus/hepatitis C virus co-infection

enthalten in: World Journal of Hepatology = 世界肝病学杂志(电子版)(英文版) | 2016-03-08

China Academic Journals (CAJ), E, 医药卫生科技 = Medicine & Public Health

von Christine U Oramasionwu | Angela DM Kashuba | Sonia Napravnik | +3

8

"Inside These Fences Is Our Own Little World": Prison-Based HIV Testing and HIV-Related Stigma Among Incarcerated Men and Women

enthalten in: AIDS education and prevention | 2016

von Kathryn E. Muessig | David L. Rosen | Claire E. Farel | +3

9

Simplification to abacavir/lamivudine + atazanavir maintains viral suppression and improves bone and renal biomarkers in ASSURE, a randomized, open label, non-inferiority trial.

in: PLoS ONE | 2014

von David A Wohl | Laveeza Bhatti | Catherine B Small | +7

10

The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit.

in: PLoS ONE | 2013

von David A Wohl | Michelle A Kendall | Judith Feinberg | +10